DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Motzer RJ, Escudier B, McDermott DF. et al
CheckMate 025 Investigators. Nivolumab versus everolimus in advanced renal-cell carcinoma.
N Engl J Med 2015;
373 (19) 1803-1813
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.